The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology
- Earn up to 21.75 CME credits | ABIM
Media Formats Choose Video Option:Online – $1,395Online + USB – $1,545Online + USB + Printed Syllabus – $1,770
Starting at$1,395.00Current Stock:
Quick Facts
a CMEinfo video production
Accredited by:Oakstone Publishing
Content by:Brigham and Women’s Hospital and
Dana-Farber Cancer Institute
Course Directors:
Maureen M. Achebe, MD, MPH
Associate Professor of Medicine
Harvard Medical School
Clinical Director
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Nancy Berliner, MD
Professor of Medicine
Harvard Medical School
Chief, Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Credits:Earn a maximum of 21.75 AMA PRA Category 1 Credits™ and 21.75 ABIM MOC points
Overview
Master Hematology CME
Gain essential knowledge with The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology online CME program. This expert-led course covers key topics such as molecular genetics, leukemia, lymphomas, and bone marrow disorders, helping you refine patient care strategies and excel on your board exam. Continuing medical education areas for practice improvement include:
- Hematopoiesis and Cytokines
- Immune and Non-immune Hemolytic Anemia
- Molecular Genetics of Cancer
- Thalassemia and Other Hemoglobinopathies
- Acquired Thrombocytopenias
- Von Willebrand Disease and Congenital Platelet Disorders
- Transfusion Medicine
- and many more…
This program is also available as part of the combined Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology CME course found here.
Topics / Speakers
Molecular Genetics of Cancer – Marios Giannakis, MD, PhD
Infections in Cancer Patients – Lindsey Baden, MD
Opioid Prescribing for Cancer-Related Pain – Kate M. Lally, MD
Communication – The Key to Excellence in End-of-Life Care – Eilann C. Santo, MD, MPH
Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD
Biology of Acute Leukemia and Myelodysplastic Syndromes – Zuzana Tothova, MD, PhD
The Evolving Treatment Landscape of the Acute Leukemias – Where Are We Now – Daniel J. DeAngelo, MD, PhD
Myelodysplastic Syndrome – Eric S. Winer, MD
Chronic Myelogenous Leukemia – Marlise R. Luskin, MD
Myeloproliferative Syndromes – Joan-Chi How, MD
Multiple Myeloma – Kenneth C. Anderson, MD
Waldenstrom Macroglobulinemia and Amyloidosis – Jorge J. Castillo, MD
Low Grade Lymphomas – Caron A. Jacobson, MD
Agressive Non-Hodgkin Lymphoma Part 1 – Diffuse Large B-Cell and Burkitt – Eric D. Jacobsen, MD
Agressive Non-Hodgkin Lymphoma Part 2 – Mantle Cell and T-Cell – Eric D. Jacobsen, MD
Hodgkin’s Lymphoma – Reid W. Merryman, MD
Diagnosis and Treatment of CLL and Related B-Cell Malignancies – Matthew S. Davids, MD
Hematopoiesis and Cytokines – David B. Sykes, MD, PhD
Acquired Bone Marrow Failure – Julie-Aurore Losman, MD, PhD
Congenital Bone Marrow Failure – Grant Rowe, MD, PhD
HLH – Sarah Nikiforow, MD
Anemia – An Overview – Robert Stern, MD
Iron Deficiency and Iron Overload – Mark D. Fleming, MD, Dphil
Immune Hemolytic Anemia – Arielle L. Langer, MD, MPH
Non-immune Hemolytic Anemia – David E. Golan, PhD, MD
Sickle Cell Disease – Maureen M. Achebe, MD, MPH
Thalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD
Disorders of Neutrophils – Nancy Berliner, MD
Acquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD
Hemophilia – Stacy E. Croteau, MD
Von Willebrand Disease and Congenital Platelet Disorders – Nathan T. Connell, MD, MPH
Congenital and Acquired Thrombophilia – Kenneth A. Bauer, MD
Managing Challenging Cases of Venous Thrombosis in Patients with Cancer – Jean M. Connors, MD
Transfusion Medicine for the Clinician – Marie A. Hollenhorst, MD, PhD
Faculty
Course Directors
Maureen M. Achebe, MD, MPH
Associate Professor of Medicine
Harvard Medical School
Clinical Director
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Nancy Berliner, MD
Professor of Medicine
Harvard Medical School
Chief, Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Faculty
Kenneth C. Anderson, MD
Kraft Family Professor of Medicine
Harvard Medical School
Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Lindsey Baden, MD
Elizabeth G. and Gary J. Nabel Family Professor
Professor of Medicine
Harvard Medical School
Director Immunocompromised Service
Division of Infectious Diseases
Department of Medicine
Brigham and Women’s Hospital
Elisabeth M. Battinelli, MD, PhD
Assistant Professor of Medicine
Harvard Medical School
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Kenneth A. Bauer, MD
Professor of Medicine
Harvard Medical School
Division of Hematology
Department of Medicine
Beth Israel Deaconess Medical Center
Jorge J. Castillo, MD
Associate Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Nathan T. Connell, MD, MPH
Associate Professor of Medicine
Harvard Medical School
Division of Hematology
Vice Chair, Department of Medicine
Brigham and Women’s Hospital
Jean M. Connors, MD
Professor of Medicine
Harvard Medical School
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Stacy E. Croteau, MD
Professor of Pediatrics
Harvard Medical School
Dana-Farber Cancer Institute
Department of Cancer and Blood Disorders Center
Boston Children’s Hospital
Matthew S. Davids, MD
Associate Professor of Medicine
Harvard Medical School
Clinical Research Director
Division of Lymphoma
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Daniel J. DeAngelo, MD, PhD
Professor of Medicine
Harvard Medical School
Chief of the Division of Leukemia
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Mark D. Fleming, MD, DPhil
S. Burt Wolbach Professor of Pathology
Harvard Medical School
Department of Pathology
Boston Children’s Hospital
Marios Giannakis, MD, PhD
Associate Professor of Medicine
Harvard Medical School
Department of Medical Oncology
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
David E. Golan, PhD, MD
Professor of Biological Chemistry and Molecular Pharmacology
Harvard Medical School
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Matthew M. Heeney, MD
Associate Professor of Pediatrics
Harvard Medical School
Dana-Farber Cancer Institute
Division of Hematology
Department of Medicine
Boston Children’s Hospital
Marie A. Hollenhorst, MD, PhD
Assistant Professor of Medicine
Harvard Medical School
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Joan-Chi How, MD
Assistant Professor of Medicine
Harvard Medical School
Chief of Hematology
Brigham and Women’s Faulkner Hospital
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Eric D. Jacobsen, MD
Assistant Professor of Medicine
Harvard Medical School
Clinical Director
Adult Lymphoma Program and Institute Physician
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Caron A. Jacobson, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Kate M. Lally, MD
Assistant Professor of Medicine
Harvard Medical School
Clinical Director, Adult Palliative Care
Department of Psychosocial Oncology and Palliative Care
Dana-Farber Cancer Institute
Division of Palliative Medicine
Department of Medicine
Brigham and Women’s Hospital
Arielle L. Langer, MD, MPH
Assistant Professor of Medicine
Harvard Medical School
Director, Thalassemia Program
Director, Women’s Bleeding and Clotting Disorders Program
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Julie-Aurore Losman, MD, PhD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Marlise R. Luskin, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Reid W. Merryman, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Sarah Nikiforow, MD
Assistant Professor of Medicine
Harvard Medical School
Medical Director
Cell Manipulation Core Facility
Technical Director
Immune Effector Cell Program
Stem Cell Transplantation Clinician
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Grant Rowe, MD, PhD
Assistant Professor of Pediatrics
Harvard Medical School
Director, BMF Clinic
Department of Hematology/Oncology
Boston Children’s Hospital
Blood Disorders Center
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Eilann C. Santo, MD, MPH
Instructor in Medicine
Harvard Medical School
Psychosocial Oncology and Palliative Care
Medical Director, HeartPal
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Robert J. Soiffer, MD
Worthington and Margaret Collette
Professor of Medicine in the Field of Hematologic Oncology
Harvard Medical School
Chief, Division of Hematologic Malignancies
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Robert Stern, MD
Assistant Professor of Medicine
Harvard Medical School
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
David B. Sykes, MD, PhD
Assistant Professor of Medicine
Harvard Medical School
Division of Hematology
Department of Medicine
Massachusetts General Hospital
Zuzana Tothova, MD, PhD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Eric S. Winer, MD
Assistant Professor of Medicine
Harvard Medical School
Clinical Director, Division of Adult Leukemia
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Accreditation / Pass Guarantee
Accreditation
Oakstone Publishing is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
Oakstone Publishing designates this enduring material for a maximum of 21.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 21.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Date of Original Release: March 15, 2025
Termination Date: March 14, 2028
CME credit is awarded upon successful completion of a course evaluation and post-test.
Learning Objectives
At the conclusion of this activity, the participant will be able to:
- Apply current/recommended hematology guidelines in clinical practice
- Perform differential diagnosis of complex clinical presentations related to hematologic disorders
- Identify/apply current therapeutic options for specific hematologic disorders
- Review and interpret up-to-date literature relevant to clinical practice in hematology
- Demonstrate knowledge of pathophysiology as it applies to the management of hematology disorders
- Apply knowledge gained to the ABIM certification/recertification hematology examinations
Intended Audience
The activity was planned for fellows/trainees, practicing hematology specialists (MDs), and other professional affiliates (internists with an interest in hematology) who are preparing to take ABIM board review or recertification examinations, or who seek CME activities to improve patient care in the areas of hematology medicine.
Board Pass Guarantee
We’re Committed to Your Success. Oakstone stands behind the quality of its board review programs. If you complete a course and do not pass your board examination, we will provide extended access to the content or credit toward the purchase of a future board review program in accordance with our CME Board Pass Guarantee policy.
This pass guarantee is a product policy offered by Oakstone and is independent of CME accreditation. Accreditation pertains only to the educational activity and does not guarantee examination outcomes.
SKU: HEX557E0
About Oakstone
About Ebix
Ebix | Oakstone Publishing
1 Ebix Way
Johns Creek, GA 30097
Copyright © 2026 Ebix Inc. Terms of Service | Privacy Policy | Sitemap